Network pharmacology of Withania somnifera against stress associated neurodegenerative diseases
- 17 January 2021
- journal article
- research article
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 21 (3) , 565-578
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)PLOS ONE, 2013
- COX‐2 in the neurodegenerative process of Parkinson's diseaseBioFactors, 2012
- Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's diseaseProgress in Neurobiology, 2012
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liverProceedings of the National Academy of Sciences, 2012
- Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicityProceedings of the National Academy of Sciences, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitroJournal of Neural Transmission, 2008
- Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticityBrain, 2008
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003